Phase I-III Immunogenicity (BSL-2 & 3) Services

The complex interplay between drugs and the immune system is vital for understanding drug safety and efficacy. Our CRO stands as your trusted partner for phase I-III immunogenicity testing, providing comprehensive services in both Biosafety Level (BSL) 2 and BSL-3 containment environments to fully assess the immunogenic potential of your drug candidate and ensure patient safety.


Unveiling the Immune Response

Your Trusted Partner for Phase I-III Immunogenicity Testing in BSL-2 and BSL-3 Containment

Our team of experts offer a comprehensive suite of immunogenicity testing services tailored to your specific clinical trial needs. Our expertise encompasses:

1. Phase I-III Trial Support:

  • Design and implement immunogenicity assays customized to your drug candidate and clinical trial phase, ensuring reliable and relevant data collection.
  • Conduct a wide range of assays, including anti-drug antibody (ADA) detection and characterization, cytokine analysis, and T-cell assays, to provide a comprehensive picture of the immune response.
  • Employ state-of-the-art analytical techniques, including flow cytometry, ELISA, and multiplex assays (including MSD), for high sensitivity and specificity.

2. BSL-2 and BSL-3 Containment Capabilities:

  • Conduct immunogenicity testing for both BSL-2 and BSL-3 agents in dedicated, high-containment laboratory facilities to ensure safe handling of potentially hazardous materials.
  • Implement strict protocols and rigorous biosafety procedures to protect personnel and the environment.
  • Maintain compliance with all relevant regulatory requirements and institutional biosafety guidelines.

3. Data Analysis and Interpretation:

  • Employ sophisticated data analysis tools and statistical methods to interpret immunogenicity data accurately and identify potential safety signals.
  • Provide detailed reports and expert interpretation of the results, outlining key findings and their implications for drug development and clinical trial design.

4. Regulatory Support and Documentation:

  • Assist with regulatory submissions by providing comprehensive immunogenicity data packages that meet all regulatory requirements.
  • Offer expert guidance on navigating regulatory expectations and ensuring compliance with ICH guidelines for immunogenicity testing.

5. Quality Control and Assurance:

  • Implement rigorous quality control procedures throughout the entire testing process to ensure the accuracy, reliability, and integrity of data.
  • Maintain GLP compliance and employ a dedicated quality assurance team to oversee all aspects of study conduct.

Unwavering Commitment to Patient Safety and Data Integrity

Partner with Us for a Clearer View of the Immune Response

We understand the critical importance of patient safety and data integrity in clinical research. Our unwavering commitment to quality extends to all aspects of our immunogenicity testing services. We strictly adhere to BSL-2 and BSL-3 containment guidelines, implement rigorous quality control measures, and employ a dedicated team of experts to ensure the safety of our staff, the environment, and the integrity of your research data.

Contact us today to discuss your specific immunogenicity testing needs and embark on a journey towards safe and effective drug development.

Basic Template Image